You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review
|
|---|---|
| Published in |
Radiation Oncology, December 2012
|
| DOI | 10.1186/1748-717x-7-210 |
| Pubmed ID | |
| Authors |
Maurizio Amichetti, Dante Amelio, Giuseppe Minniti |
| Abstract |
Stereotactic radiosurgery (SRS) is an important treatment option for intracranial lesions. Many studies have shown the effectiveness of photon-SRS for the treatment of skull base (SB) tumours; however, limited data are available for proton-SRS.Several photon-SRS techniques, including Gamma Knife, modified linear accelerators (Linac) and CyberKnife, have been developed and several studies have compared treatment plan characteristics between protons and photons.The principles of classical radiobiology are similar for protons and photons even though they differ in terms of physical properties and interaction with matter resulting in different dose distributions.Protons have special characteristics that allow normal tissues to be spared better than with the use of photons, although their potential clinical superiority remains to be demonstrated.A critical analysis of the fundamental radiobiological principles, dosimetric characteristics, clinical results, and toxicity of proton- and photon-SRS for SB tumours is provided and discussed with an attempt of defining the advantages and limits of each radiosurgical technique. |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Belgium | 2 | 2% |
| Egypt | 1 | 1% |
| Unknown | 94 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 17 | 18% |
| Researcher | 14 | 14% |
| Student > Doctoral Student | 10 | 10% |
| Student > Ph. D. Student | 9 | 9% |
| Student > Bachelor | 8 | 8% |
| Other | 21 | 22% |
| Unknown | 18 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 46% |
| Physics and Astronomy | 10 | 10% |
| Neuroscience | 5 | 5% |
| Nursing and Health Professions | 4 | 4% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 6 | 6% |
| Unknown | 24 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2012.
All research outputs
#15,258,711
of 22,689,790 outputs
Outputs from Radiation Oncology
#1,037
of 2,046 outputs
Outputs of similar age
#180,077
of 278,890 outputs
Outputs of similar age from Radiation Oncology
#17
of 30 outputs
Altmetric has tracked 22,689,790 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,046 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,890 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.